Rankings
▼
Calendar
COLL FY 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
FY 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2M
Gross Profit
$1M
87.6% margin
Operating Income
-$94M
-5498.7% margin
Net Income
-$94M
-5504.1% margin
EPS (Diluted)
$-3.88
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$78M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$162M
Total Liabilities
$27M
Stockholders' Equity
$135M
Cash & Equivalents
$153M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$1M
-$171,000
+976.0%
Operating Income
-$94M
-$27M
-249.7%
Net Income
-$94M
-$27M
-245.5%
← FY 2015
All Quarters
Q1 2016 →